| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |